Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ellison

Showing results (531-540 of 574) with videos related to

Pageof 58
Sort By:
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14M Y Deng, M Sill, D Sturm, et al.
Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Nature Communications|April 9, 2014
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomesRobert Huether, Li Dong, Xiang Chen, et al.
Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Cancer Cell|April 15, 2020
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasScott Ryall, Michal Zapotocky, Kohei Fukuoka, et al.
Pageof 58

Showing results (531-540 of 574) with videos related to

Sort By:
Pageof 58
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14M Y Deng, M Sill, D Sturm, et al.
Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Nature Communications|April 9, 2014
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomesRobert Huether, Li Dong, Xiang Chen, et al.
Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Cancer Cell|April 15, 2020
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasScott Ryall, Michal Zapotocky, Kohei Fukuoka, et al.
Pageof 58